PDS Biotechnology (PDSB) Tops Q3 EPS by 2c

PDS Biotechnology (NASDAQ: PDSB) reported Q3 EPS of ($0.19), $0.02 better than the analyst estimate of ($0.21).

For earnings history and earnings-related data on PDS Biotechnology (PDSB) click here.

You May Also Be Interested In

• Gulfport Energy and Mobility Global to join S&P SmallCap 600
• Magnolia Said In Lead To Acquire Wildfire For Over $4 Billion - Bloomberg
• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story